Research laboratories at the Perkins are organised into the following programs and centres.
The mission of the Perkins Cancer Program is to transform cancer outcomes by uncovering the molecular and cellular causes, advancing early detection methods, and developing precision treatments for poor prognosis cancers, specifically women’s cancers (breast, ovarian), liver cancer, pancreatic cancer, melanoma and head and neck cancers.
The Cardiovascular Science and Diabetes Program at the Perkins is an integrated research pipeline spanning discovery, biomedical engineering and clinical research, focused on protecting hearts and blood vessels, predicting risks and pioneering cardiovascular disease treatments. Researchers investigate heart disease, diabetes, kidney disease and cancer.
The Genome Biology and Genetic Diseases Program aims to decode the genetic and epigenetic drivers of disease and ageing, harness artificial intelligence to develop personalised diagnostic tools, and continue to explore treatments and preventive strategies for neurological and neuromuscular conditions.
All donations of $2 and over are tax deductible in Australia.
Perkins is registered with the Australian Taxation Office as a Deductible Gift Recipient (DGR): Charitable Fundraising Authority No DGR CC20761
The Harry Perkins Institute of Medical Research recognises Australia’s first healers and scientists, the Aboriginal and Torres Strait Islander peoples. We acknowledge the Whadjuk people of the Noongar nation, the Traditional Custodians of the lands where we live and work, and pay respects to their elders past and present.
